Abstract
This thesis investigated whether the development of metastases in patients treated for hormone-sensitive breast cancer can be predicted on the basis of the DNA methylation profile of the tumor. The thesis consists of a main study investigating the prognostic value of DNA methylation in Dutch patients, and a number of technical studies that made the analyses in the main study possible. The conclusion of the study is that DNA methylation has a predictive value for the occurrence of metastases in women treated for hormone-sensitive breast cancer, but that this predictive value is no better than already existing clinical factors.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 4 Jul 2022 |
Place of Publication | Maastricht |
Publisher | |
Print ISBNs | 9789464195316 |
DOIs | |
Publication status | Published - 2022 |
Keywords
- breast cancer
- DNA methylation
- prognosis
- endocrine treatment